# A Study of Prometic Plasminogen IV Infusion in Subjects With Hypoplasminogenemia

> **NCT02690714** · PHASE2,PHASE3 · COMPLETED · sponsor: **Prometic Biotherapeutics, Inc.** · enrollment: 15 (actual)

## Conditions studied

- Hypoplasminogenemia
- Congenital Plasminogen Deficiency

## Interventions

- **BIOLOGICAL:** Plasminogen (Human) intravenous

## Key facts

- **NCT ID:** NCT02690714
- **Lead sponsor:** Prometic Biotherapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05-04
- **Primary completion:** 2017-12-17
- **Final completion:** 2018-10-08
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2021-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02690714

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02690714, "A Study of Prometic Plasminogen IV Infusion in Subjects With Hypoplasminogenemia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02690714. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*